menu search

Glaxosmithkline beats expectations boosted by covid-19 treatment. the stock is up.

The British drugmaker's antibody treatment for Covid-19 generated sales of £1.3 billion during the qua...

April 27, 2022, 4:55 am

Ambrx biopharma's arx788 selected for phase 2 adaptive breast cancer trial

Quantum Leap Healthcare Collaborative and Ambrx Biopharma Inc (NYSE: AMAM) have announced the selection of Ambrx's antibody-drug conjugate (ADC) A...

April 26, 2022, 11:54 am

Astrazeneca says tremelimumab accepted for us priority review for imfinzi combo for liver cancer treatment

AstraZeneca PLC (LSE:AZN) said its Biologics License Application (BLA) for tremelimumab, an anti-CTLA4 antibody, has been accepted for Priority Revie...

April 25, 2022, 2:39 am

Regeneron (regn) regen-cov bla review extended by 3 months

Regeneron (REGN) biologics license application for antibody cocktail REGEN-COV (casirivimab and imdevim...

April 18, 2022, 1:32 pm

Revive therapeutics touts publication of positive research data with bucillamine in coronavirus

Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) announced the publication of a scientific article evaluating the impact of medication, including Bucill...

April 18, 2022, 11:44 am

Actinium (atnm) up on commercialization deal with immedica

Actinium (ATNM) out-licenses exclusive rights to Iomab-B, an antibody radiation conjugate for facilitat...

April 13, 2022, 6:04 pm

Cytodyn touts publication of paper on suppression of human and simian immunodeficiency virus replication with leronlimab

CytoDyn Inc, a late-stage biotechnology company developing its flagship drug leronlimab for multiple indications, has revealed the publication of a p...

April 12, 2022, 11:24 am

antibody treatments for covd-19 face challenges in the u.s.

With the emergence of the highly transmissible Omicron variant, the authorized antibody treatments of c...

April 8, 2022, 10:32 am

Twist bioscience inks antibody discovery pact with medisix therapeutics

Twist Bioscience Corporation (NASDAQ: TWST) and MediSix Therapeutics have collaborated to discover novel antibodies against five undisclosed targe...

April 7, 2022, 12:14 pm

Astrazeneca has cracked a whole new cancer treatment market, but how much is worth?

Research on AstraZeneca PLC (LSE:AZN) by JP Morgan underlined the scale of the opportunity on offer for the micro-cap life sciences companies developi...

April 7, 2022, 8:38 am

Zai lab to present new oncology research at 2022 aacr annual meeting

-  First preview of preclinical data for ZL-1218, an anti-CCR8 antibody, in an oral presentation...

April 6, 2022, 8:01 am

Coronvirus tally: fda pulls glaxo covid treatment ahead of panel meeting on next steps for 2022

GlaxoSmithKline's GSK, +1.87% IV drug for COVID-19 should no longer be used because it is likely ineffective against the omicron subvariant that now a...

April 6, 2022, 6:28 am

Why adagio therapeutics stock is soaring today

Adagio Therapeutics Inc (NASDAQ: ADGI) is trading higher Wednesday after the company announced its investigational drug adintrevimab (ADG20) was the...

March 30, 2022, 10:23 am

Vir's stock is up 12% after news it will join the s&p smallcap 600

Shares of Vir Biotechnology Inc. VIR, +15.99% were up 12.8% in premarket trading on Wednesday, the day after it was announced that the stock will join...

March 30, 2022, 9:31 am

Astrazeneca (azn) gets eu nod for covid-19 antibody cocktail

The European Commission approves AstraZeneca's (AZN) Evusheld for the pre-exposure prophylaxis of COVID-19 infection in a broad patient population....

March 28, 2022, 1:33 pm

Fda says current dose of gsk-vir's covid-19 therapy unlikely to work against omicron subvariant

The FDA said that the currently authorized 500mg dose of GlaxoSmithKline Plc (NYSE: GSK) and Vir Biotechnology Inc's (NASDAQ: VIR) COVID-19 ...

March 28, 2022, 10:47 am

Astrazeneca's covid drug bags eu approval

AstraZeneca PLC (LSE:AZN) has received EU marketing authorisation for its Evusheld antibody combination...

March 28, 2022, 5:13 am

Why is biondvax (bvxv) stock up today?

BVXV stock is climbing today on news that BiondVax has struck a deal to pursue a range of antibody trea...

March 24, 2022, 1:15 pm

Here's why biondvax pharmaceuticals shares are rising

Biondvax Pharmaceuticals Ltd - ADR (NASDAQ: BVXV) shares are trading higher by 32.1% at $1.81 after the company announced it signed a definitive coll...

March 24, 2022, 12:03 pm

Soligenix's covid-19 vaccine candidate as booster neutralizes delta, omicron variants

Soligenix Inc (NASDAQ: SNGX) announced the results of a booster vaccination study using CiVax (heat-stable COVID-19 subunit vaccine program) in non...

March 17, 2022, 9:44 am


Search within

Pages Search Results: